Download Citation
Article Source:
A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome
Ohtake A,
Abe Y,
Murayama K,
Shiraishi H,
Osaka H,
et al.
(2026)
A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome.
PLOS ONE 21(7): e0332283.
https://doi.org/10.1371/journal.pone.0332283